Dr Reddy's Laboratories Ltd
NSE:DRREDDY

Watchlist Manager
Dr Reddy's Laboratories Ltd Logo
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Watchlist
Price: 1 350.9 INR 0.71%
Market Cap: 1.1T INR
Have any thoughts about
Dr Reddy's Laboratories Ltd?
Write Note

Dr Reddy's Laboratories Ltd
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dr Reddy's Laboratories Ltd
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Other Income
â‚ą9.1B
CAGR 3-Years
25%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Other Income
â‚ą7.8B
CAGR 3-Years
42%
CAGR 5-Years
17%
CAGR 10-Years
15%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Other Income
â‚ą15.8B
CAGR 3-Years
25%
CAGR 5-Years
12%
CAGR 10-Years
12%
Lupin Ltd
NSE:LUPIN
Total Other Income
â‚ą1.7B
CAGR 3-Years
0%
CAGR 5-Years
-8%
CAGR 10-Years
3%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Other Income
â‚ą942.9m
CAGR 3-Years
-12%
CAGR 5-Years
5%
CAGR 10-Years
-4%
M
Mankind Pharma Ltd
NSE:MANKIND
Total Other Income
â‚ą768.7m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dr Reddy's Laboratories Ltd
Glance View

Market Cap
1.1T INR
Industry
Pharmaceuticals
Economic Moat
Narrow

In the bustling world of pharmaceuticals, Dr. Reddy's Laboratories Ltd. stands as a testament to innovation and resilience. Founded in 1984 by Dr. K. Anji Reddy, the company embarked on a journey to provide affordable and accessible medicine. Dr. Reddy's merged scientific rigor with a clear vision to eliminate health disparities worldwide. From creating complex generics and active pharmaceutical ingredients (APIs) to providing differentiated formulations, the company has built a strong foundation in both developed markets, like the United States and Europe, as well as in emerging markets such as India, Russia, and the CIS countries. This global footprint ensures that while many pharmaceutical companies are battling regulatory challenges and pricing pressures, Dr. Reddy's stays agile and competitive. The company's revenue streams primarily derive from its diverse portfolio of generic drugs, APIs, branded formulations, biologics, and proprietary products. Each sector is a strategic puzzle piece that enhances its market presence and ensures supply chain efficiency. Dr. Reddy's invests heavily in research and development to bolster its pipeline of future medications, aiming to address unmet medical needs and introduce value-added products. By leveraging strategic alliances and forging partnerships in development and distribution, the company adeptly navigates the complex landscape of the pharmaceutical industry, ensuring sustainable growth and reaffirming its commitment to affordable healthcare globally.

DRREDDY Intrinsic Value
621.53 INR
Overvaluation 54%
Intrinsic Value
Price

See Also

What is Dr Reddy's Laboratories Ltd's Total Other Income?
Total Other Income
9.1B INR

Based on the financial report for Sep 30, 2024, Dr Reddy's Laboratories Ltd's Total Other Income amounts to 9.1B INR.

What is Dr Reddy's Laboratories Ltd's Total Other Income growth rate?
Total Other Income CAGR 5Y
6%

Over the last year, the Total Other Income growth was 70%. The average annual Total Other Income growth rates for Dr Reddy's Laboratories Ltd have been 25% over the past three years , 6% over the past five years .

Back to Top